
Naomi Michele Simon MD
Professor of Psychiatry, NYU Medical School. Director, Anxiety and Complicated Grief Program, NYU Langone Health. Vice Chair, Research Faculty Development and Mentoring, Department of Psychiatry Senior Advisor, Steven A. Cohen Military Family Clinic
Join to View Full Profile
1 Park AveFl 8New York, NY 10016
Phone+1 212-263-7419
Dr. Simon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- New York Presbyterian Hospital (Columbia Campus)/New York State Psychiatric InstituteResidency, Psychiatry, 1992 - 1996
- Harvard Medical SchoolClass of 1992
Certifications & Licensure
- NY State Medical License 1994 - 2026
- MA State Medical License 1996 - 2025
- American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- Combination of Paroxetine CR and Quetiapine for the Treatment of Refractory Generalized Anxiety Disorder Start of enrollment: 2004 Feb 01
- Duloxetine for Social Anxiety Disorder: Prediction of Long Term Outcome Start of enrollment: 2004 Jun 01
- SSRI Administration to Reduce Acute Stress Disorder Symptoms and Prevent Depression and PTSD in Physical Trauma Victims Start of enrollment: 2005 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsAcute and long-term effects of COVID-19 on brain and mental health: A narrative review.J Douglas Bremner, Scott J Russo, Richard Gallagher, Naomi M Simon
Brain, Behavior, and Immunity. 2025-01-01 - Depression is Associated with Treatment Response Trajectories in Adults with Prolonged Grief Disorder: A Machine Learning Analysis.Adam Calderon, Matthew Irwin, Naomi M Simon, M Katherine Shear, Christine Mauro
Medrxiv. 2024-12-12 - Ecological momentary assessment in prolonged grief research: Feasibility, acceptability, and measurement reactivity.Emily H Mintz, Emma R Toner, Alexa M Skolnik, Alicia Pan, Madelyn R Frumkin
Death Studies. 2024-12-02
Journal Articles
- Factors Related to Migraine Patients’ Decisions to Initiate Behavioral Migraine Treatment Following a Headache Specialist’s Recommendation: A Prospective Observational...Richard B Lipton, Naomi M Simon, Scott Powers, Rachel Sobolev, Sarah Azarchi, Pain Medicine
Press Mentions
- Effectively Reduce Stress and Treat Anxiety Disorders Without Antidepressants – SciTechDailyNovember 11th, 2022
- Effectively Reducing Stress and Treating Anxiety Disorders Without Antidepressant DrugsNovember 11th, 2022
- Effectively Reduce Stress and Treat Anxiety Disorders Without AntidepressantsNovember 11th, 2022
- Join now to see all
Grant Support
- Elucidating Neural Mechanisms and Sex Differences in Response to Mindfulness Based Stress Reduction in Generalized Anxiety DisorderNEW YORK UNIVERSITY SCHOOL OF MEDICINE2021–2026
- Randomized placebo controlled trial to determine the biological signature of cannabidiol as a treatment for social anxiety disorderNEW YORK UNIVERSITY SCHOOL OF MEDICINE2022–2025
- 2/4-Optimizing Treatment Of Complicated GriefNational Institute Of Mental Health2009–2012
- The Utility Of Threat Detection In Generalized Social Anxiety DisorderNational Institute Of Mental Health2011
- Depression DNA Damage And Telomeres: A Chronic Stress Model Of Accelerated AgingNational Institute Of Mental Health2007–2011
- Treatment Refractory Panic DisorderNational Institute Of Mental Health2000–2004
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: